Evaxion Biotech A/S
NASDAQ:EVAX

Watchlist Manager
Evaxion Biotech A/S Logo
Evaxion Biotech A/S
NASDAQ:EVAX
Watchlist
Price: 6.09 USD 5.36% Market Closed
Market Cap: 38.5m USD

Operating Margin
Evaxion Biotech A/S

-120.3%
Current
-4 266%
Average
-4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-120.3%
=
Operating Profit
-9.2m
/
Revenue
7.7m

Operating Margin Across Competitors

No Stocks Found

Evaxion Biotech A/S
Glance View

Market Cap
38.5m USD
Industry
Biotechnology

Evaxion Biotech A/S discovers and develops novel immunotherapies for cancer and infectious diseases. The firm decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is developing a pipeline of product candidates. In addition, Evaxion develops portfolio of vaccines to prevent bacterial and viral infections.

EVAX Intrinsic Value
3.5 USD
Overvaluation 43%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-120.3%
=
Operating Profit
-9.2m
/
Revenue
7.7m
What is the Operating Margin of Evaxion Biotech A/S?

Based on Evaxion Biotech A/S's most recent financial statements, the company has Operating Margin of -120.3%.

Back to Top